You are viewing a free limited preview of CytomX Therapeutics, Inc.
For Full Access: Unlock This Company Report For $99 or Upgrade To PrivCo Premium Subscription For Full Site-Wide Access

CytomX Therapeutics, Inc.

Private Company Ticker Symbol™: (CYTXTHP)

Business Summary

CytomX Therapeutics, Inc. is a privately-held, venture capital backed biotechnology company that specializes in proteolytically-activated antibodies. Founded in 2008 by Patrick S. Daugherty, CytomX Therapeutics, Inc. is headquartered in Santa Barbara, California.

Overview & Corporate Organization

Basic Information

Company Tags:VC Backed
Year Founded:2008
Fiscal Year End:12/31
City:Santa Barbara
State/Province:California
Country:United States
Phone:View
Website:www.cytomx.com

Corporate Organization

Brands:
CytomX

Industry Information

Industry Codes

PICS™:1500107
NAICS:View
SIC:View

PrivCo Industries (Sector > Industry > Sub-Industry)

Technology > Biotechnology > Biotherapeutics

The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.

VC/Funding Activity

PrivCo's VC/Funding Activity table for CytomX Therapeutics, Inc. displays the venture capital rounds, angel investments, debt or other funding raised by CytomX Therapeutics, Inc..
All data before 2006 is completely free to view! To access data from 2006 onward:
Get Full Access To This Report Now! $99 Single Company Access
 
or Upgrade to PrivCo Premium Subscription Instant Full Site-Wide Access
Currently 50% Off Until May. 31!
DateInvestorRoundInvestor Type
Sep. 2010ViewBCorporate
Sep. 2010ViewBVenture Capital
DetailsTotal Round B View
Aug. 2012ViewB-1Venture Capital
Aug. 2012ViewB-1Venture Capital
Aug. 2012ViewB-1Venture Capital
DetailsTotal Round B-1 View
Total of Funding Shown Above View

Missing a deal? Tell us about it! tips@privco.com

Supplemental Resources

For additional information on CytomX Therapeutics, Inc., you can see the following:

You are viewing a free limited preview of CytomX Therapeutics, Inc.
For Full Access: Unlock This Company Report For $99 or Upgrade To PrivCo Premium Subscription For Full Site-Wide Access